Two COVID-19 vaccines show safety, strong immunity in infant model
California fully reopens after being 1st to shut in pandemic
15 June 2021Junk food diet may boost risk of dangerous driving among truck/lorry drivers
15 June 2021Two COVID-19 vaccines show safety, strong immunity in infant model
A group of scientists led by researchers at the University of North Carolina at Chapel Hill, Weill Cornell Medicine and NewYork-Presbyterian reported that the Moderna mRNA vaccine and a protein-based vaccine candidate elicited durable neutralizing antibody responses to SARS-CoV-2 in pre-clinical research. There were no adverse effects.
